• British Study Links EZH2 Enzyme to Poorer Myeloma Patient Survival
  • Type of Multiple Myeloma May Affect Responses to Darzalex, Study Finds
  • Darzalex Now Available to Certain Myeloma Patients in Scotland Through its NHS
  • Myeloma UK Launches New Clinical Trial to Develop Therapies for High-Risk Myeloma
  • Venclexta, Velcade, and Dexamethasone Combo Shows Promising Results in Multiple Myeloma Trial
  • Amiloride, an Old Diuretic Therapy, Can Kill Multiple Myeloma, Spanish Researchers Find
  • First Myeloma Patient in Study Treated with New CAR T-Cell Therapy bb21217
  • Cellectar’s CLR 131 Shows Positive Phase 1 Trial Results for Heavily Treated Myeloma Patients
  • Acupuncture Helps to Manage Effects of HSCT and Chemo in Myeloma Patients, Study Says
  • Patient Recruitment Begins for Phase 1 Trial of P-BCMA-101 CAR T-Cell Therapy for Multiple Myeloma
  • Japanese Regulator Approves Darzalex Combo for Relapsed or Refractory Multiple Myeloma
  • Autolus Advances New Myeloma CAR T-cell Therapy in Clinical Trial